Vivanza Biosciences Limited share price
BSE: VIVANZA
Key numbers
- Market cap
- ₹ 7.1 Cr
- Current price
- ₹ 1.77
- 52-week high / low
- ₹ 3 / 2
- Stock P/E
- 14.8
- Book value
- ₹ 1.1
- Dividend yield
- 0.00%
- ROCE
- 6.0%
- ROE
- 9.4%
- Debt to equity
- 2.34
- Sales growth (3 yrs)
- 86.7%
- Profit growth (3 yrs)
- -13.4%
- 1-year return
- -13.7%
About Vivanza Biosciences Limited
Vivanza Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India. It offers pharmaceuticals in various categories; injectable products, including antifungals, antibiotics, antivirals, and other products for hospital and clinical use; Vivanza medical gloves for medical and surgical use; therapeutic index injection; and veterinary products and feed. The company was incorporated in 1982 and is headquartered in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 9 | 55 | 45 | 6 | 9 |
| Operating profit | 0 | 1 | 0 | -0 | -0 |
| Net profit | 0 | 1 | 0 | -0 | 0 |
| EPS (₹) | 0.02 | 0.14 | 0.05 | -0.11 | 0.04 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.